EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches

Tiago Ribeiro iD, Kristín Jónsdóttir, Rene Hernandez-Bautista, Natália Gonçalves Silva iD, Begoña Sánchez-Astráin, Afshin Samadi iD, Finnur F Eiriksson, Margrét Thorsteinsdóttir iD, Siegfried Ussar iD, Ralph Urbatzka iD

Marine Drugs · 2023

DOI: 10.3390/md21090498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Tiago Ribeiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Avenida General Norton de Matos, s/n, 4450-208 Mat…. Hauptthemen laut MEDLINE: Lipid Metabolism, Cyanobacteria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, European Regional Development Fund (ERDF), FCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyanobacteria have demonstrated their therapeutic potential for many human diseases. In this work, cyanobacterial extracts were screened for lipid reducing activity in zebrafish larvae and in fatty-acid-overloaded human hepatocytes, as well as for glucose uptake in human hepatocytes and ucp1 mRNA induction in murine brown adipocytes. A total of 39 cyanobacteria strains were grown and their biomass fractionated, resulting in 117 chemical fractions. Reduction of neutral lipids in zebrafish larvae was observed for 12 fractions and in the human hepatocyte steatosis cell model for five fractions. The induction of ucp1 expression in murine brown adipocytes was observed in six fractions, resulting in a total of 23 bioactive non-toxic fractions. All extracts were analyzed by untargeted UPLC-Q-TOF-MS mass spectrometry followed by multivariate statistical analysis to prioritize bioactive strains. The metabolite profiling led to the identification of two markers with lipid reducing activity in zebrafish larvae. Putative compound identification using mass spectrometry databases identified them as phosphatidic acid and aromatic polyketides derivatives—two compound classes, which were previously associated with effects on metabolic disorders. In summary, we have identified cyanobacterial strains with promising lipid reducing activity, whose bioactive compounds needs to be identified in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismCyanobacteriaAnimalsZebrafishHumansMiceHepatocytesLarva

Stichwörter der Autor:innen

cyanobacterialipidsmetabolic diseasemetabolite profilesteatosisthermogenesis

Autor:innen und Institutionen

  • Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Avenida General Norton de Matos, s/n, 4450-208 Matosinhos, Portugal.
  • Faculty of Sciences, University of Porto, Rua do Campo Alegre, 1021, 4169-007 Porto, Portugal.
  • Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland.
  • RG Adipocytes & Metabolism, Institute for Diabetes & Obesity, Helmholtz Diabetes Center, Helmholtz Munich, 85764 Neuherberg, Germany.
  • Joint Laboratory of Applied Ecotoxicology, Korea Institute of Science and Technology Europe (KIST EU), Campus E7.1, 66123 Saarbrucken, Germany.
  • ArcticMass, Sturlugata 8, 102 Reykjavik, Iceland.

ORCID-Profile: Tiago Ribeiro, Natália Gonçalves Silva, Afshin Samadi, Margrét Thorsteinsdóttir, Siegfried Ussar, Ralph Urbatzka

Förderung

  • Fundação para a Ciência e Tecnologia
  • European Regional Development Fund (ERDF)
  • FCT
  • ATLANTIDA
  • Norte Portugal Regional Operational Program

Zitieren

APA

Ribeiro, T., Jónsdóttir, K., Hernandez-Bautista, R., Silva, N. G., Sánchez-Astráin, B., Samadi, A., Eiriksson, F. F., Thorsteinsdóttir, M., Ussar, S., & Urbatzka, R. (2023). Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches. Marine Drugs. https://doi.org/10.3390/md21090498

Vancouver

Ribeiro T, Jónsdóttir K, Hernandez-Bautista R, Silva NG, Sánchez-Astráin B, Samadi A, et al. Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches. Marine Drugs. 2023. doi:10.3390/md21090498

BibTeX
@article{Ribeiro2023,
  author = {Ribeiro, Tiago and Jónsdóttir, Kristín and Hernandez-Bautista, Rene and Silva, Natália Gonçalves and Sánchez-Astráin, Begoña and Samadi, Afshin and Eiriksson, Finnur F and Thorsteinsdóttir, Margrét and Ussar, Siegfried and Urbatzka, Ralph},
  title = {Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21090498}
}
Kostenlos starten →